c.balogun

TL2 Moderator · Kochi

Contributes reviews on supplier material. Based in Kochi.

Joined 6 August 2025 · last posted 7d

75 posts, newest first. Showing up to 150.

Which categories are strict and which are relaxed, honestly Replied, post #36 · Start Here › Welcome · 21 Jul 2026 · 5 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
How shortages have affected compounding permissions Replied, post #43 · Access › Shortages · 16 Jul 2026 · 30 likes Worth separating two things that post #39 runs together. Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #74 · Analytics › Home & field testing · 11 Jul 2026 · 18 likes On post #70 — agreed on the reasoning, with one qualification. False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #85 · Analytics › HPLC & UHPLC · 29 Jun 2026 · 32 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #32 · Compounds › Secretagogues & GH axis · 28 Jun 2026 · 0 likes Picking up post #29: that is the part I would want checked first. Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #114 · Practice › Reconstitution · 17 Jun 2026 · 14 likes On post #110 — agreed on the reasoning, with one qualification. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #37 · Compounds › Secretagogues & GH axis · 16 Jun 2026 · 12 likes Worth separating two things that post #33 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #61 · Meta › Announcements · 9 Jun 2026 · 2 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
Does dual agonism explain the effect size, or is it dose? Replied, post #14 · Compounds › Tirzepatide · 3 Jun 2026 · 12 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
The arithmetic of an intermediate dose between two label steps Replied, post #3 · Practice › Dosing & titration · 23 May 2026 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
Packaging that arrived damaged: documenting it properly Replied, post #13 · Sourcing › Logistics · 22 May 2026 · 18 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #34 · Clinical › Bloodwork · 19 May 2026 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #19 · Practice › Storage & stability · 8 May 2026 · 1 like Coming back to post #17, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Coming back to: Measurement error in a self-reported exposure Replied, post #26 · Evidence › Study critique · 28 Apr 2026 · 32 likes This follows post #23 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #4 · Compounds › Tirzepatide · 27 Apr 2026 · 18 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #31 · Start Here › Welcome · 21 Apr 2026 · 10 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #11 · Compounds › Repair & healing peptides · 13 Apr 2026 · 0 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
Grapefruit: why this class is not the class that cares Replied, post #51 · Practice › Interactions · 18 Mar 2026 · 17 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
Research-use-only status: what it means legally and practically Replied, post #14 · Compounds › Other compounds · 14 Mar 2026 · 0 likes Coming back to post #12, because the follow-up matters more than the original answer. Distinguishing marketed research compounds from true chemical synthesis: some…
A payment that went through twice: how it was resolved Replied, post #20 · Sourcing › Payments · 10 Mar 2026 · 13 likes Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter.
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #15 · Lounge › Introductions · 8 Mar 2026 · 16 likes Coming back to post #13, because the follow-up matters more than the original answer. No judgment: people come to this community from all backgrounds and with all…
Documenting a payment dispute without naming and shaming Replied, post #4 · Sourcing › Payments · 4 Mar 2026 · 2 likes the opening post is right about the mechanism and I think understates the practical bit. Payment mechanics: most suppliers accept bank transfer, crypto, and some accept…
Waist circumference technique and its repeatability Replied, post #56 · Outcomes › Progress reports · 25 Feb 2026 · 3 likes I read post #54 twice before replying, because I had assumed the opposite. Medication changes: escalating dose, or adding or removing other medications, can affect the…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #41 · Outcomes › Progress reports · 12 Feb 2026 · 4 likes This follows post #38 rather than contradicting it. Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the…
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #13 · Outcomes › Body composition · 4 Feb 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Amylin receptor signalling and satiety — what changed since Replied, post #17 · Pharmacology › Receptor biology · 17 Jan 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #54 · Access › Pricing · 5 Jan 2026 · 7 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
Pharmacy supply in the UK and the questions you will be asked Replied, post #2 · Regional › UK & Ireland · 3 Jan 2026 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Coming back to: A newcomer's list of things that confused me, and the fixes Started this topic · Start Here › Welcome · 30 Dec 2025 · 0 likes Posting this under the heading it deserves: A newcomer's list of things that confused me, and the fixes Everything below is what sits behind that. Question in the…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #2 · Practice › Side effects · 30 Dec 2025 · 18 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #71 · Compounds › Semaglutide · 17 Dec 2025 · 0 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
Pinch or no pinch, and how needle length changes the answer — the long version Started this topic · Practice › Administration · 13 Dec 2025 · 3 likes On the subject in the title: Pinch or no pinch, and how needle length changes the answer — the long version Working notes rather than a conclusion. I have read the…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #5 · Sourcing › Red flags · 2 Dec 2025 · 1 like Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #13 · Compounds › Tirzepatide · 1 Dec 2025 · 15 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
Oral semaglutide bioavailability and its variability between people Replied, post #18 · Compounds › Oral incretins · 30 Nov 2025 · 0 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
Thyroid function tests during substantial weight change Replied, post #138 · Clinical › Bloodwork · 17 Nov 2025 · 2 likes I read post #136 twice before replying, because I had assumed the opposite. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw…
Meeting a protein target on a suppressed appetite Replied, post #32 · Nutrition & Training › Protein & intake · 1 Nov 2025 · 0 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #88 · Devices › Cold chain · 10 Oct 2025 · 26 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
Insurance and replacement policies, compared — the long version Replied, post #16 · Sourcing › Logistics · 16 Sep 2025 · 13 likes Coming back to post #14, because the follow-up matters more than the original answer. Declaring contents accurately: declaring accurately reduces intervention risk. A…
What a purity-only report leaves out Replied, post #11 · Sourcing › Independent verification · 11 Sep 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #87 · Data & Tools › Datasets · 9 Sep 2025 · 24 likes Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.
Aggregated purity results across four services, with caveats — a second dataset Replied, post #64 · Data & Tools › Datasets · 8 Sep 2025 · 6 likes Collection methods: ask how the data were collected. Longitudinal tracking over months is stronger than retrospective recall. Prospective measurement (done while…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #24 · Analytics › Method validation · 8 Sep 2025 · 26 likes I read post #22 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #76 · Sourcing › Regulatory · 11 Aug 2025 · 7 likes This follows post #73 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #11 · Analytics › COA interpretation · 25 Jul 2025 · 2 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #78 · Compounds › Repair & healing peptides · 23 Jul 2025 · 27 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
Pregnancy as an absolute contraindication — the long version Replied, post #3 · Safety › Contraindications · 7 Jun 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #90 · Compounds › Tirzepatide · 21 May 2025 · 12 likes post #89 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
Pregnancy as an absolute contraindication Replied, post #46 · Safety › Contraindications · 18 May 2025 · 17 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
A supplier that answers analytical questions with restated claims Replied, post #78 · Sourcing › Red flags · 17 May 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #3 · Documentation › Doc review · 17 May 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Follow-up: Documentation that appears only after payment Replied, post #62 · Sourcing › Red flags · 9 May 2025 · 18 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
Ipamorelin selectivity claims and where they came from Replied, post #35 · Compounds › Secretagogues & GH axis · 6 May 2025 · 0 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #15 · Access › Pricing · 18 Mar 2025 · 1 like Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #54 · Practice › Reconstitution · 14 Mar 2025 · 16 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
Reading an MS report that only gives you a single number Replied, post #27 · Analytics › Mass spectrometry · 12 Mar 2025 · 30 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
Second pass at: Retatrutide mass and identity: what a report should show Started this topic · Compounds › Retatrutide · 6 Mar 2025 · 10 likes Second pass at: Retatrutide mass and identity: what a report should show — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 (…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #107 · Sourcing › Regulatory · 4 Mar 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Validating a method you did not develop — does this still hold? Replied, post #57 · Analytics › Method validation · 28 Feb 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Distinguishing a deletion sequence by mass alone Replied, post #128 · Analytics › Mass spectrometry · 24 Feb 2025 · 13 likes Resolution: "high resolution" commonly means
Follow-up: What other technical communities get right that we do not Replied, post #24 · Lounge › Off topic · 23 Feb 2025 · 16 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
SURPASS-2 and the comparator dose question that will not go away Replied, post #106 · Compounds › Tirzepatide · 16 Jan 2025 · 22 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
Follow-up: Individual participant data versus aggregate data Replied, post #110 · Evidence › Meta-analyses · 12 Jan 2025 · 0 likes Coming back to post #108, because the follow-up matters more than the original answer. Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates…
Recovery when intake is low: what to cut first Replied, post #11 · Nutrition & Training › Resistance training · 9 Jan 2025 · 1 like post #10 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
The topic list is dense — is that deliberate? Replied, post #73 · Meta › Site feedback · 27 Dec 2024 · 9 likes I read post #71 twice before replying, because I had assumed the opposite. Search and findability: if you searched for something and did not find it, report what you…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #41 · Compounds › Cagrilintide & amylin analogues · 27 Dec 2024 · 23 likes On post #37 — agreed on the reasoning, with one qualification. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are…
Coming back to: When to suspect the method rather than the sample Replied, post #120 · Analytics › Method validation · 23 Dec 2024 · 28 likes Picking up post #117: that is the part I would want checked first. Range: the concentration range over which the method has been validated. Going outside the validated…
Identical chromatograms across two different lots Replied, post #66 · Sourcing › Red flags · 23 Dec 2024 · 10 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #61 · Access › Insurance & coverage · 9 Dec 2024 · 0 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
Time to steady state after a dose increase Replied, post #130 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 30 likes post #129 is right about the mechanism and I think understates the practical bit. Hepatic metabolism: the degree to which each compound is hepatically metabolised…
High-resolution MS on aggregates and what it can see — one year on Replied, post #57 · Analytics › Mass spectrometry · 21 Aug 2024 · 0 likes This follows post #54 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
Blind submission and why it changes minds Replied, post #32 · Sourcing › Independent verification · 9 Aug 2024 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
Guidelines revision: what changed and why Replied, post #93 · Meta › Announcements · 27 Jul 2024 · 10 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
Guidelines revision: what changed and why Replied, post #78 · Meta › Announcements · 27 Jul 2024 · 4 likes Worth separating two things that post #74 runs together. Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what…
The mass-error checker and its intended scope Replied, post #68 · Data & Tools › Calculators · 22 Jun 2024 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.